HIV/AIDS clinical trials at UC Irvine

2 in progress, 0 open to eligible people

Showing trials for

  • Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically

    Sorry, in progress, not accepting new patients

    Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.

    Los Angeles, California

  • PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

    Sorry, not currently recruiting here

    The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of the potent, broadly neutralizing anti-HIV monoclonal antibodies (mAb) PGT121.414.LS alone and in combination with VRC07-523LS soon after birth in infants exposed to HIV-1.

    Los Angeles, California and other locations

Our lead scientists for HIV/AIDS research studies include .

Last updated: